Dr. Beverly Jean Long, MD

Dr. Long practices at First Physicians Group in Nokomis, Florida.

Dr. Long's NPI, 1932497245, was assigned on July 20, 2011. Dr. Long graduated from Frederick P. Whiddon College of Medicine in 2011. Dr. Long holds Florida license ME146963.

Dr. Long's primary practice is First Physicians Group, at 200 Healthcare Way, Nokomis, FL 34275 in Sarasota County. The practice phone is (941) 917-8720.

Dr. Long's primary practice is First Physicians Group in Nokomis, Florida. Dr. Long is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Dr. Long to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Long practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Long's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Long is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Long's licenses on file in 5 states: Florida, California, Maryland, District of Columbia and Minnesota.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Long treats.

CMS data shows 613 Medicare services from Dr. Long across 12 procedure codes in 2024, for 313 Medicare patients. Medicare paid $84,350 for them.

CMS counts 313 Medicare patients who saw Dr. Long in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Long's median patient age at 70, with 99% women.

In 2024, Dr. Long wrote 192 Medicare Part D claims for 106 patients. 84% of them were for generic drugs. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $8,507 in total drug cost. In 2023, CMS named 133 claims across 5 drugs.

Dr. Long accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of removal of the uterus by Dr. Long, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Long, published from 2013 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Endometrial Neoplasms, Paget Disease, Extramammary and Uterine Hemorrhage. Dr. Long has published most often in Gynecol Oncol. Dr. Long's most frequent co-authors are Jamie N. Bakkum-Gamez, MD, William A. Cliby, MD and Yuan James Rao, MD.

Dmand AI links Dr. Long to 5 clinical trials, 2 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Carcinosarcoma, Carcinoma, Endometrioid and COVID-19. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 20 general payments to Dr. Long from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $1,472.

Dr. Long graduated from Frederick P. Whiddon College of Medicine in 2011.

Dr. Long is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.